ABAT vs HCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ABAT

56.1
AI Score
VS
ABAT Wins

HCAT

47.9
AI Score

Investment Advisor Scores

ABAT

56score
Recommendation
HOLD

HCAT

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABAT HCAT Winner
Forward P/E 37.7358 7.764 HCAT
PEG Ratio 0 0 Tie
Revenue Growth 697.1% -10.9% ABAT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 56.1/100 47.9/100 ABAT
Profit Margin 0.0% -87.7% ABAT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABAT 1M: -24.3% · 3M: -38.2% HCAT 1M: +1.0% · 3M: +67.2%

Current Technical Phase

ABAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.5%), weak momentum, RSI 34

RSI (14): 33.9 · Price: $2.09

HCAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.8% over 20 days), RSI 52

RSI (14): 52.1 · Price: $2.09

Fundamentals Snapshot

Metric ABAT HCAT
Market Cap
Forward P/E -11.3 22.6
Trailing P/E
Revenue (TTM)
Revenue Growth 7.0% -0.1%
Gross Margin -0.4% 0.5%
Operating Margin -4.4% -0.1%
EPS -0.52 -3.57
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ABAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.